Accelr8 Posts Sharp Decline in Fiscal Q3 Revenue; Re-Evaluating Market, Firm May Miss BACcelr8r Launch Date | GenomeWeb

The original version of this article incorrectly reported that Accelr8 said in December that it plans to launch its BACceler8r product in fiscal 2006. In fact, the company made this projection in October 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.